UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 17, 2020
Accession Number:
0001193125-20-007888
Submission Type:
POS AM
CIK:
0001628738
Company Name:
Audentes Therapeutics, Inc.
File Number:
333-222680